Modular Medical, Inc.
MODD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.06 | 0.02 | -0.01 |
| FCF Yield | -45.15% | -38.64% | -80.18% | -34.43% |
| EV / EBITDA | -1.61 | -1.90 | -1.00 | -1.42 |
| Quality | ||||
| ROIC | -104.01% | -137.77% | -209.63% | -165.47% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.84 | 0.80 | 0.79 | 0.55 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -16.36% | -23.74% | -22.64% | -71.38% |
| Safety | ||||
| Net Debt / EBITDA | 0.71 | 0.47 | 0.17 | 0.60 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -5.42 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 3.74 | 0.00 |
| Cash Conversion Cycle | -86.09 | -381.16 | -195.11 | -555.97 |